Additionally, the soluble serum concentrations of ACE2 and TMPRSS2 were elevated in severe COVID-19 patients, compared to those with non-severe COVID-19 (P < 0.01 and P < 0.001, respectively). The gene discussed is ACE2; the disease is COVID-19.